Ikena Oncology Inc (IKNA)
1.41
+0.10
(+7.63%)
USD |
NASDAQ |
May 07, 16:00
1.415
0.00 (0.00%)
Pre-Market: 20:00
Ikena Oncology Profit Margin (Quarterly): -2.96K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.96K% |
| September 30, 2023 | -1.46K% |
| June 30, 2023 | -854.0% |
| March 31, 2023 | -267.6% |
| December 31, 2022 | -258.7% |
| September 30, 2022 | -270.8% |
| June 30, 2022 | -5.36K% |
| March 31, 2022 | -497.6% |
| Date | Value |
|---|---|
| December 31, 2021 | 13.83% |
| September 30, 2021 | -387.5% |
| June 30, 2021 | -357.3% |
| March 31, 2021 | -279.7% |
| December 31, 2020 | -40.08K% |
| September 30, 2020 | -219.9% |
| June 30, 2020 | -163.9% |
| March 31, 2020 | -215.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-40.08K%
Minimum
Dec 2020
13.83%
Maximum
Dec 2021
-3.35K%
Average
-318.5%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.62% |
| Return on Assets | -37.71% |
| Return on Invested Capital | -44.62% |
| Operating Margin (Quarterly) | -3.32K% |
| Return on Net Operating Assets | -631.4% |